Wipro partners with bio-tech firm Pandorum Technologies

17 Mar 2022 , 01:33 AM

Wipro and Pandorum Technologies a biotechnology company working in the field of tissue engineering and regenerative medicine today announced a long-term partnership Together the companies will focus on development of technologies that shorten time-to-market and maximize patient outcome during RD and clinical trials of regenerative medicine The partnership combines the Artificial Intelligence AI capabilities of Wipro Holmes with Pandorums expertise in regenerative medicine The initial focus of collaboration will be on bio-engineered liquid cornea and will expand across the product pipeline including lung and liver regenerative tissues Wipro Holmes AI-based decision support solution will provide insights on the potential outcomes of specific formulations apply advanced algorithms to predict and improve the efficacy of therapeutics and help in clinical study design The combined vision of Pandorum and Wipro is to build an AI system that learns from the multidimensional data coming out of Pandorums RD pipeline at the cellular tissue organoid and organ levels and provides actionable insights Wipro Holmes capability in deriving insights from phenotypes genotypes and clinical progression assessments will complement Pandorums state-of-the-art capabilities in tissue regeneration and regenerative medicine Pandorum is on the cusp of entering clinical stage and the exponential partnership with Wipro merging Pandorums expertise and artificial intelligence will unlock the power of regenerative medicine